Natural xanthones as α-Mangostin induce vasorelaxation involving key gating residues in the S6 domain of BK channels

This study identifies the natural xanthone $\alpha$-Mangostin as a potent vasorelaxant that activates BK channels by binding to specific gating residues (I308, L312, and A316) in the S6 domain, thereby stabilizing the open state and shifting voltage activation to more negative potentials.

The Gist

The Big Picture: A Natural "Relaxation Switch"

Imagine your blood vessels are like garden hoses. When they are tight and squeezed, water (blood) can't flow easily, and your blood pressure goes up. To lower blood pressure, you need to loosen those hoses.

Scientists have long known that a fruit called the Mangosteen (specifically a compound inside it called $\alpha$-Mangostin) helps lower blood pressure. But for years, nobody knew how it worked or what it touched inside the body. It was like knowing a key opens a door, but not knowing which lock it fits.

This paper solves that mystery. The researchers discovered that $\alpha$-Mangostin works by flipping a specific "relaxation switch" on the walls of your blood vessels.

The Characters in the Story

1. The BK Channel (The Gatekeeper):
   Think of the cells in your blood vessel walls as a busy factory. Inside these cells, there are tiny gates called BK channels. When these gates open, they let potassium ions (tiny electrical particles) flow out. This flow acts like a brake, telling the muscle cell to relax and stop squeezing the blood vessel.

   • Analogy: If the blood vessel is a rubber band, the BK channel is the finger that lets the rubber band snap back to its relaxed state.

2. $\alpha$-Mangostin (The Key):
   This is the active ingredient from the Mangosteen fruit. The study found that this molecule is a master key for the BK channel gates.

3. The Problem:
   Normally, these gates are very picky. They only open when the cell gets a specific signal (like a sudden spike in calcium or a strong electrical charge). In a resting state, they often stay closed, keeping the blood vessels slightly tense.

How the Study Works (The "How-To")

The researchers didn't just guess; they put the Mangostin through a rigorous test drive:

• The Lineup: They tested $\alpha$-Mangostin against many different types of "gates" (potassium channels) in a lab.

  • Result: It ignored most of them but went straight for the BK channels, opening them wide open. It was like a key that only fits the front door of the house, ignoring all the windows and side doors.

• The Mechanism (How it opens the gate):
  The researchers looked at the gate under a microscope (using electrical recordings). They found that $\alpha$-Mangostin doesn't just force the gate open; it changes the rules of the game.

  • The Shift: Normally, the gate needs a lot of energy (voltage) to open. $\alpha$-Mangostin lowers the bar. It makes the gate so sensitive that it opens with very little effort.
  • The "Sticky" Effect: Once the gate opens, it stays open longer. It's like greasing a rusty hinge; the door swings open easily and doesn't slam shut immediately. This keeps the blood vessel relaxed for a longer time.

• Finding the Lock (The Binding Site):
  Where does the Mangostin actually stick? The researchers used computer models and genetic mutations (changing tiny parts of the gate) to find the exact spot.

  • The Location: They found it lodges itself in a tiny pocket inside the gate, specifically in a section called the S6 domain.
  • The Analogy: Imagine the gate is a complex machine with gears. $\alpha$-Mangostin wedges itself between two specific gears (residues I308, L312, and A316). By sticking there, it prevents the gears from locking back into the "closed" position, forcing the machine to stay in "open."

• The Real-World Test:
  Finally, they took actual mouse aorta (blood vessel) tissue, squeezed it tight with a drug, and then added $\alpha$-Mangostin.

  • Result: The tissue instantly relaxed. But, when they blocked the BK channels with a specific inhibitor first, the Mangostin did nothing. This proved that the Mangostin only works because it activates those specific BK channels.

Why This Matters

1. It Explains the "Superfood" Myth: Many people eat Mangosteen supplements for heart health. This paper proves why it works: it physically relaxes blood vessels by activating BK channels.
2. Safety: The researchers checked if this "key" accidentally opened other dangerous doors (like the hERG channel, which, if messed with, can cause heart rhythm problems). Fortunately, $\alpha$-Mangostin ignored those dangerous doors, suggesting it might be safer than synthetic drugs.
3. Future Medicine: Now that we know exactly where and how this molecule works, drug designers can build better, stronger medicines based on this natural structure to treat high blood pressure without the side effects of current drugs.

The Bottom Line

The Mangosteen fruit contains a natural compound ($\alpha$-Mangostin) that acts like a molecular wedge. It jams itself into the "relaxation gates" of your blood vessels, making them easier to open and harder to close. This keeps your blood vessels loose, your blood flowing smoothly, and your blood pressure down. It's nature's own way of greasing the hinges of your circulatory system.

Technical Summary

1. Problem Statement

• Context: Polyphenolic compounds (nutraceuticals) like those found in Garcinia mangostana (mangosteen) are widely consumed for health benefits, including hypertension management. However, their specific active ingredients, molecular targets, and mechanisms of action remain poorly defined.
• Specific Gap: While $\alpha$-Mangostin has been shown to lower blood pressure and relax aortic rings, the molecular target and the precise biophysical mechanism were unclear. Previous studies suggested interactions with K2P channels (TREK-1) but yielded contradictory results regarding the site of action in vascular tissue.
• Objective: To identify the primary molecular target of $\alpha$-Mangostin responsible for vasorelaxation and to elucidate the structural and biophysical mechanism of its activation.

2. Methodology

The study employed a multi-faceted approach combining electrophysiology, molecular biology, structural modeling, and tissue physiology:

• Pharmacological Screening: High-throughput screening of $\alpha$-Mangostin against a panel of potassium channels (K2P, Kv, Kir, and BK families) expressed in HEK293 cells to determine selectivity.
• Electrophysiology:
  • Macroscopic Currents: Whole-cell patch-clamp recordings in HEK293 cells to analyze voltage dependence ($V_{1/2}$), conductance-voltage ($G-V$) relationships, and activation/deactivation kinetics.
  • Single-Channel Recordings: Inside-out patch-clamp recordings to analyze open probability ($P_o$), dwell times (open/closed), and burst kinetics.
  • Nanodomain Reconstitution: Co-expression of BK channels ($\alpha/\beta1$) with Cav1.2 channels in CHO-K1 cells via microinjection to mimic physiological "BK-Cav nanodomains" where local $Ca^{2+}$ spikes occur.
  • Tissue Physiology: Isometric tension recordings of mouse aortic rings pre-contracted with noradrenaline to assess vasorelaxation, with and without the specific BK channel blocker Iberiotoxin (IbTx).
• Structural & Computational Analysis:
  • Molecular Docking: Docking of $\alpha$-Mangostin into the pore cavity of BK channels (using PDB structures 6v3g for $Ca^{2+}$-free and 6v38 for $Ca^{2+}$-bound states).
  • Mutagenesis: Site-directed mutagenesis of residues in the S6 transmembrane segment (e.g., I308, L312, A316) to functionally validate the predicted binding site.
  • Competition Assays: Using quaternary ammonium ions (TPA, THexA) to test for steric hindrance and binding site overlap within the pore.
• pH Dependence: Testing activation potency at varying pH levels to assess the role of ionization states.

3. Key Contributions

• Target Identification: Established BK channels (specifically the BK$\alpha$/$\beta1$ heteromer) as the primary molecular target of $\alpha$-Mangostin in vascular smooth muscle, rather than K2P channels.
• Mechanism Elucidation: Demonstrated that $\alpha$-Mangostin acts as a state-independent activator that shifts the voltage dependence of activation to more negative potentials and significantly slows channel deactivation.
• Structural Mapping: Precisely localized the binding site to the inner pore cavity below the Selectivity Filter (SF), specifically involving the S6 gating helix.
• Residue Identification: Identified critical gating residues I308, L312, and A316 in the S6 domain as essential for $\alpha$-Mangostin binding and activation.
• Physiological Validation: Confirmed that the vasorelaxant effect of $\alpha$-Mangostin in native tissue is strictly dependent on functional BK channels.

4. Key Results

• Selectivity: $\alpha$-Mangostin potently activated BK channels (20–24 fold increase in current) while inhibiting several K2P (TWIK-1, TWIK-2, TASK-3) and Kv1.3 channels. It had no effect on hERG channels (reducing cardiotoxicity risk).
• Biophysical Effects:
  • Voltage Shift: Application of 10 $\mu$M $\alpha$-Mangostin shifted the half-maximal activation voltage ($V_{1/2}$) by -53 mV in BK$\alpha$ and -82 mV in BK$\alpha$/$\beta1$ channels, allowing channels to open at physiological resting potentials.
  • Kinetics: The compound markedly slowed deactivation (increasing the time constant $\tau$ by ~7-fold in BK$\alpha$ and ~27-fold in BK$\alpha$/$\beta1$), leading to prolonged channel openings.
  • Single-Channel: Increased open probability ($P_o$) from ~0.002 to ~0.77 at +40 mV. It stabilized the open state and reduced brief closures (flickering) within bursts.
  • State Independence: Activation occurred even when channels were held in the closed state, indicating the drug binds to both closed and open conformations.
• Binding Site Localization:
  • Competition: $\alpha$-Mangostin competed with THexA (a pore blocker), suggesting a binding site in the central cavity below the SF.
  • Docking: Predicted binding in a pocket formed by S6 helices between residues I308 and V319.
  • Mutagenesis: Mutations I308A, L312M, and A316P drastically reduced or abolished the voltage shift induced by $\alpha$-Mangostin, confirming these residues as critical for binding.
  • pH Sensitivity: Activation potency was pH-dependent (stronger at pH 8.5, weaker at pH 6), suggesting the negative charge of the molecule (likely from a deprotonated hydroxyl group) is critical for interaction.
• Physiological Relevance:
  • In BK-Cav nanodomains, $\alpha$-Mangostin potentiated currents triggered by local $Ca^{2+}$ influx, mimicking physiological conditions.
  • In mouse aortic rings, $\alpha$-Mangostin induced robust relaxation (>85% reduction in force). This effect was completely abolished by pre-treatment with Iberiotoxin (IbTx), proving BK channel mediation.

5. Significance

• Mechanistic Clarity: The study resolves the long-standing ambiguity regarding the antihypertensive mechanism of mangosteen xanthones, identifying BK channel activation as the core driver.
• Drug Discovery: It defines a specific pharmacophore (xanthone) and a precise binding site (S6 pore cavity) for developing novel BK channel activators. This is crucial for treating conditions like hypertension, overactive bladder, and pulmonary hypertension, where current drugs have failed in Phase III trials.
• Safety Profile: The lack of effect on hERG channels suggests a favorable safety profile regarding cardiac arrhythmia risks, a common issue with K-channel modulators.
• Nutraceutical Validation: Provides a molecular basis for the health claims associated with mangosteen supplements, moving beyond anecdotal evidence to defined pharmacology.
• Gating Mechanism Insight: The findings support the hypothesis that small molecules can modulate BK channels by stabilizing the open state via interactions with the hydrophobic S6 gating ring, potentially preventing "dewetting" of the pore.

In conclusion, this paper establishes $\alpha$-Mangostin as a potent, natural BK channel opener that acts via a specific binding site in the S6 pore domain, providing a structural and functional blueprint for future therapeutic development targeting vascular tone.